Panagora Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-128
| Closed | -$5K | – | 2747 |
|
|
2021
Q2 | $5K | Sell |
128
-23,149
| -99% | -$904K | ﹤0.01% | 2508 |
|
|
2021
Q1 | $1.13M | Buy |
23,277
+2,675
| +13% | +$130K | 0.01% | 971 |
|
|
2020
Q4 | $2.02M | Buy |
20,602
+6,252
| +44% | +$614K | 0.01% | 710 |
|
|
2020
Q3 | $990K | Buy |
14,350
+7,600
| +113% | +$524K | 0.01% | 901 |
|
|
2020
Q2 | $713K | Buy |
6,750
+5,301
| +366% | +$560K | ﹤0.01% | 1062 |
|
|
2020
Q1 | $129K | Buy |
1,449
+674
| +87% | +$60K | ﹤0.01% | 1601 |
|
|
2019
Q4 | $89K | Hold |
775
| – | – | ﹤0.01% | 1825 |
|
|
2019
Q3 | $48K | Buy |
775
+7
| +0.9% | +$434 | ﹤0.01% | 1975 |
|
|
2019
Q2 | $60K | Buy |
+768
| New | +$60K | ﹤0.01% | 2060 |
|
|
2018
Q3 | – | Sell |
-53
| Closed | -$5K | – | 2489 |
|
|
2018
Q2 | $5K | Sell |
53
-2,476
| -98% | -$234K | ﹤0.01% | 2311 |
|
|
2018
Q1 | $319K | Sell |
2,529
-3,551
| -58% | -$448K | ﹤0.01% | 1533 |
|
|
2017
Q4 | $1.02M | Sell |
6,080
-3,136
| -34% | -$524K | ﹤0.01% | 1128 |
|
|
2017
Q3 | $2.9M | Buy |
9,216
+3,787
| +70% | +$1.19M | 0.01% | 725 |
|
|
2017
Q2 | $1.61M | Buy |
+5,429
| New | +$1.61M | 0.01% | 942 |
|
|
2016
Q2 | – | Sell |
-2,165
| Closed | -$246K | – | 2366 |
|
|
2016
Q1 | $246K | Buy |
2,165
+85
| +4% | +$9.66K | ﹤0.01% | 1591 |
|
|
2015
Q4 | $319K | Buy |
+2,080
| New | +$319K | ﹤0.01% | 1459 |
|